Home
Conditions
Melanoma Stage III

Clinical trial condition

Melanoma Stage III

Explore clinical trials studying Melanoma Stage III. Study availability and eligibility vary by location and protocol.

35 public trials 15 recruiting studies

Refine in advanced search Browse all conditions

Melanoma Stage III trial results

Recruiting

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

NCT05970497

Conditions: Cancer, Cutaneous Melanoma, Melanoma, +13 more
Locations: UCLA Health Los Angeles, California, United States

Mission Dermatology Center Rancho Santa Margarita, California, United States

BRCR Global Weston, Florida, United States

IU Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

View all 15 locations

View Trial Details

Recruiting

FMT to Convert Response to Immunotherapy

NCT05251389

Conditions: Melanoma, Melanoma Stage III, Melanoma Stage IV, +11 more
Locations: Antoni van Leeuwenhoek Amsterdam, Netherlands

View Trial Details

Recruiting

Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial

NCT05652673

Conditions: Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Immunotherapy, +15 more
Locations: Erasmus MC Rotterdam, Netherlands

View Trial Details

Recruiting

Versatile Ampification Single-Molecule Detection in Liquid Biopsy

NCT05940311

Conditions: Liquid Biopsy, Melanoma, Melanoma (Skin), +13 more
Locations: "Regina Elena" National Cancer Institute Rome, Italy

View Trial Details

Recruiting

Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment

NCT04045691

Conditions: Melanoma, Melanoma Stage III, Melanoma Stage IV, +11 more
Locations: 11 Graz, Austria

13 Innsbruck, Austria

14 Klagenfurt, Austria

10 Linz, Austria

View all 59 locations

View Trial Details

Not yet recruiting

Clinical and Ultrasound Incidence of Rheumatologic Immune Related Adverse Events in Stage IIB-IV Melanoma Patients

NCT06780397

Conditions: Melanoma, Melanoma Stage III, Melanoma Stage IV, +12 more
Locations: Fondazione Policlinico Universitario A. Gemelli IRCCS, UOC Dermatologia Rome, Lazio, Italy

View Trial Details

Active, not recruiting

Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain

NCT03605771

Conditions: Advanced Cancer, Melanoma, Melanoma Stage III, +12 more
Locations: Hospital Virgen de los Lirios Alcoy, Alicante, Spain

Hospital Universitario Virgen de las Nieves Granada, Andalusia, Spain

Onconogranada Granada, Andalusia, Spain

Hospital Universitario Regional de Málaga Málaga, Andalusia, Spain

View all 39 locations

View Trial Details

Active, not recruiting

Adjuvant Treatment Determined By Pathological Response To Neoadjvuant Nivolumab

NCT04013854

Conditions: Melanoma, Melanoma Stage III, Neoplasms, +10 more
Locations: Duke Cancer Institute Durham, North Carolina, United States

Lancaster General Hospital Lancaster, Pennsylvania, United States

Abramson Cancer Center, University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Active, not recruiting

IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients

NCT04562129

Conditions: Inoperable Disease, Melanoma, Melanoma Stage III, +12 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Active, not recruiting

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

NCT04305145

Conditions: Chemically-Induced Disorders, Colitis, Colonic Diseases, +24 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Melanoma Stage III

Melanoma Stage III trial results

Related conditions